Read More Pharma Industry News Chance Pharmaceuticals raises $30m in Series C for inhalation therapies Chance Pharmaceuticals, a Chinese clinical-stage biotech company focused on inhalation therapies for debilitating diseases, has raised $30 million… bySrinathNovember 7, 2021